These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 3125992

  • 1. The influence of a hyperthermia treatment on chemically induced tumor initiation and progression in mouse skin.
    Mitchel RE, Morrison DP, Gragtmans NJ.
    Carcinogenesis; 1988 Mar; 9(3):379-85. PubMed ID: 3125992
    [Abstract] [Full Text] [Related]

  • 2. Hyperthermia and phorbol ester tumor promotion in mouse skin.
    Mitchel RE, Morrison DP, Gragtmans NJ, Jevcak JJ.
    Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
    [Abstract] [Full Text] [Related]

  • 3. Beta-radiation-induced resistance to MNNG initiation of papilloma but not carcinoma formation in mouse skin.
    Mitchel RE, Gragtmans NJ, Morrison DP.
    Radiat Res; 1990 Feb; 121(2):180-6. PubMed ID: 2305036
    [Abstract] [Full Text] [Related]

  • 4. Tumorigenesis and carcinogenesis in mouse skin treated with hyperthermia during stage I or stage II of tumor promotion.
    Mitchel RE, Morrison DP, Gragtmans NJ.
    Carcinogenesis; 1987 Dec; 8(12):1875-9. PubMed ID: 3119245
    [Abstract] [Full Text] [Related]

  • 5. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
    Miller DR, Viaje A, Rotstein J, Aldaz CM, Conti CJ, Slaga TJ.
    Cancer Res; 1989 Jan 15; 49(2):410-4. PubMed ID: 2491955
    [Abstract] [Full Text] [Related]

  • 6. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 7. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
    Rehman I, Lowry DT, Adams C, Abdel-Fattah R, Holly A, Yuspa SH, Hennings H.
    Mol Carcinog; 2000 Apr 15; 27(4):298-307. PubMed ID: 10747294
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD, Scribner NK, McKnight B, Mottet NK.
    Cancer Res; 1983 May 15; 43(5):2034-41. PubMed ID: 6403231
    [Abstract] [Full Text] [Related]

  • 9. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
    Abdel-Fattah R, Glick A, Rehman I, Maiberger P, Hennings H.
    Int J Cancer; 2006 Feb 01; 118(3):527-31. PubMed ID: 16094607
    [Abstract] [Full Text] [Related]

  • 10. Malignant progression of mouse skin papillomas treated with ethylnitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine, or 12-O-tetradecanoylphorbol-13-acetate.
    O'Connell JF, Klein-Szanto AJ, Digiovanni DM, Fries JW, Slaga TJ.
    Cancer Lett; 1986 Mar 01; 30(3):269-74. PubMed ID: 2870794
    [Abstract] [Full Text] [Related]

  • 11. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
    Slaga TJ.
    Environ Health Perspect; 1986 Sep 01; 68():27-32. PubMed ID: 3096709
    [Abstract] [Full Text] [Related]

  • 12. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
    Hennings H, Lowry DT, Yuspa SH, Mock B, Potter M.
    Mol Carcinog; 1997 Sep 01; 20(1):143-50. PubMed ID: 9328445
    [Abstract] [Full Text] [Related]

  • 13. Potent inhibitory effects of suicide inhibitors of P450 isozymes on 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene initiated skin tumors.
    Alworth WL, Viaje A, Sandoval A, Warren BS, Slaga TJ.
    Carcinogenesis; 1991 Jul 01; 12(7):1209-15. PubMed ID: 1906378
    [Abstract] [Full Text] [Related]

  • 14. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Feb 01; 441():1-201. PubMed ID: 12595922
    [Abstract] [Full Text] [Related]

  • 15. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
    Verma AK, Boutwell RK.
    Carcinogenesis; 1980 Mar 01; 1(3):271-6. PubMed ID: 22283009
    [Abstract] [Full Text] [Related]

  • 16. Vitamin E is a complete tumor promoter in mouse skin.
    Mitchel RE, McCann R.
    Carcinogenesis; 1993 Apr 01; 14(4):659-62. PubMed ID: 8472330
    [Abstract] [Full Text] [Related]

  • 17. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
    Ewing MW, Conti CJ, Phillips JL, Slaga TJ, DiGiovanni J.
    J Natl Cancer Inst; 1989 May 03; 81(9):676-82. PubMed ID: 2496233
    [Abstract] [Full Text] [Related]

  • 18. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH.
    APMIS Suppl; 1994 May 03; 41():1-38. PubMed ID: 7946481
    [Abstract] [Full Text] [Related]

  • 19. Induction of papillomas with a high probability of conversion to malignancy.
    Hennings H, Shores R, Mitchell P, Spangler EF, Yuspa SH.
    Carcinogenesis; 1985 Nov 03; 6(11):1607-10. PubMed ID: 2414025
    [Abstract] [Full Text] [Related]

  • 20. Chronic exposure to ionizing radiation as a tumor promoter in mouse skin.
    Mitchel RE, Trivedi A.
    Radiat Res; 1992 Feb 03; 129(2):192-201. PubMed ID: 1734450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.